Cargando…

Canine prostate models in preclinical studies of minimally invasive interventions: part II, benign prostatic hyperplasia models

Canine prostate is widely used as animal model in the preclinical evaluation of emerging therapeutic interventions. Spontaneous benign prostatic hyperplasia (BPH) is common in adult intact male dogs with two distinct pathological types: glandular and complex form of prostatic hyperplasia. The comple...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Fei, Báez-Díaz, Claudia, Sánchez-Margallo, Francisco Miguel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503960/ https://www.ncbi.nlm.nih.gov/pubmed/28725598 http://dx.doi.org/10.21037/tau.2017.03.62

Ejemplares similares

Canine prostate models in preclinical studies of minimally invasive interventions: part I, canine prostate anatomy and prostate cancer models
por: Sun, Fei, et al.
Publicado: (2017)

Prostatic artery embolization with polyethylene glycol microspheres: evaluation in a canine spontaneous benign prostatic hyperplasia model
por: Lucas Cava, Vanesa, et al.
Publicado: (2020)

Prostatic artery embolization: magnetic resonance image (MRI) findings in the early detection of prostate infarction in a canine spontaneous benign prostatic hyperplasia model
por: Lucas-Cava, Vanesa, et al.
Publicado: (2021)

Update on minimally invasive surgery and benign prostatic hyperplasia
por: Chung, Amanda S.J., et al.
Publicado: (2018)

Minimally Invasive Treatment in Benign Prostatic Hyperplasia (BPH)
por: Sciacqua, L. V., et al.
Publicado: (2023)

Clinical predictive factors in prostatic artery embolization for symptomatic benign prostatic hyperplasia: a comprehensive review
por: Sun, Fei, et al.
Publicado: (2020)

Prostatic urethral lift: A minimally invasive treatment for benign prostatic hyperplasia
por: Garcia, Cindy, et al.
Publicado: (2015)

Update on the management of benign prostatic hyperplasia and the role of minimally invasive procedures
por: Franco, Juan V.A., et al.
Publicado: (2023)

Minimally invasive simple prostatectomy for a case of giant benign prostatic hyperplasia
por: Zeng, Qin-Song, et al.
Publicado: (2017)

Intraprostatic ozone therapy: A minimally invasive approach in benign prostatic hyperplasia
por: Hussain, Shabbir, et al.
Publicado: (2017)

An Update on Minimally Invasive Surgery for Benign Prostatic Hyperplasia: Techniques, Risks, and Efficacy
por: Srinivasan, Aditya, et al.
Publicado: (2020)

Benign Prostatic Hyperplasia
Publicado: (2015)

Comparison of the Efficacy and Safety of Minimally Invasive Simple Prostatectomy and Endoscopic Enucleation of Prostate for Large Benign Prostatic Hyperplasia
por: Li, Jinze, et al.
Publicado: (2021)

Establishment of hormone-induced canine benign prostatic hyperplasia model: A prospective, controlled study
por: Yuan, Bing, et al.
Publicado: (2022)

Evaluation of biomarker canine-prostate specific arginine esterase (CPSE) for the diagnosis of benign prostatic hyperplasia
por: Pinheiro, Dora, et al.
Publicado: (2017)

Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia
por: Chughtai, Bilal, et al.
Publicado: (2021)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Transurethral plasmakinetic resection of the prostate is a reliable minimal invasive technique for benign prostate hyperplasia: a meta-analysis of randomized controlled trials
por: Wang, Kai, et al.
Publicado: (2015)

Prostatic artery occlusion: initial findings on pathophysiological response in a canine prostate model
por: Lucas-Cava, Vanesa, et al.
Publicado: (2022)

Minimally invasive devices for treating lower urinary tract symptoms in benign prostate hyperplasia: technology update
por: Aoun, Fouad, et al.
Publicado: (2015)

Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer
por: Jedinak, Andrej, et al.
Publicado: (2015)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Effect of Pulsed Electromagnetic Field Therapy on Prostate Volume and Vascularity in the Treatment of Benign Prostatic Hyperplasia: A Pilot Study in a Canine Model
por: Leoci, Raffaella, et al.
Publicado: (2014)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk
por: Hung, S-C, et al.
Publicado: (2013)

iTIND: the second-generation temporary implantable nitinol device for minimally invasive treatment of benign prostatic hyperplasia
por: Balakrishnan, Dhivya, et al.
Publicado: (2020)

Newer Minimally Invasive Treatment Modalities to Treat Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia
por: Dahm, Philipp, et al.
Publicado: (2021)

Alteration of Gut Microbes in Benign Prostatic Hyperplasia Model and Finasteride Treatment Model
por: An, Jinho, et al.
Publicado: (2023)

Non-invasive urinary metabolomic profiling discriminates prostate cancer from benign prostatic hyperplasia
por: Pérez-Rambla, Clara, et al.
Publicado: (2017)

3D printed model to assist endovascular prostate artery embolization for benign prostatic hyperplasia
por: Dalla, Shiv, et al.
Publicado: (2022)

Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma
por: Christudoss, Pamela, et al.
Publicado: (2011)

Expression and Localization of Aquaporins in Benign Prostate Hyperplasia and Prostate Cancer
por: Hwang, Insang, et al.
Publicado: (2012)

Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia
por: Yu, Haining, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bmrvpembv8uaipo23fiaob1c3p